We are live on ! Find out more
Pacer Advisors

Pacer Advisors Portfolio holdings

AUM $35.6B
1-Year Est. Return 18.19%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
+18.19%
3 Year Est. Return
+46.13%
5 Year Est. Return
+70.99%
10 Year Est. Return
+394.12%
AUM
$47.3B
AUM Growth
+$3.18B
Cap. Flow
+$116M
Cap. Flow %
0.24%
Top 10 Hldgs %
11.39%
Holding
2,836
New
148
Increased
1,004
Reduced
1,103
Closed
268

Top Buys

Rank Stock Value
1
ABNB icon
Airbnb
ABNB
+$541M
2
QCOM icon
Qualcomm
QCOM
+$532M
3
CVX icon
Chevron
CVX
+$514M
4
COP icon
ConocoPhillips
COP
+$495M
5
COR icon
Cencora
COR
+$473M

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$559M
2
GILD icon
Gilead Sciences
GILD
+$542M
3
LNG icon
Cheniere Energy
LNG
+$523M
4
LYB icon
LyondellBasell Industries
LYB
+$457M
5
VTRS icon
Viatris
VTRS
+$441M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 17.84%
2 Technology 17.7%
3 Energy 16.46%
4 Industrials 10.01%
5 Healthcare 8.36%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FDMT icon
1376
4D Molecular Therapeutics
FDMT
$543M
-544
Closed -$11.4K
FOLD
1377
DELISTED
Amicus Therapeutics
FOLD
-2,597
Closed -$25.8K
GERN icon
1378
Geron
GERN
$949M
-5,503
Closed -$23.3K
GMS
1379
DELISTED
GMS Inc
GMS
-1,474,821
Closed -$119M
HRTX icon
1380
Heron Therapeutics
HRTX
$86.9M
-1,465
Closed -$5.13K
HUMA icon
1381
Humacyte
HUMA
$182M
-593
Closed -$2.85K
HWKN icon
1382
Hawkins
HWKN
$2.94B
-2,232
Closed -$203K
IBRX icon
1383
ImmunityBio
IBRX
$7.32B
-2,478
Closed -$15.7K
IDYA icon
1384
IDEAYA Biosciences
IDYA
$3.54B
-683
Closed -$24K
IMNM icon
1385
Immunome
IMNM
$2.56B
-660
Closed -$7.99K
IMVT icon
1386
Immunovant
IMVT
$8.23B
-800
Closed -$21.1K
INMD icon
1387
InMode
INMD
$884M
-620
Closed -$11.3K
INSM icon
1388
Insmed
INSM
$22.7B
-638
Closed -$42.7K
IONS icon
1389
Ionis Pharmaceuticals
IONS
$9.25B
-960
Closed -$45.8K
IOVA icon
1390
Iovance Biotherapeutics
IOVA
$2.19B
-3,831
Closed -$30.7K
IRON icon
1391
Disc Medicine
IRON
$2.85B
-136
Closed -$6.13K
ITOS
1392
DELISTED
iTeos Therapeutics
ITOS
-205
Closed -$3.04K
JANX icon
1393
Janux Therapeutics
JANX
$950M
-439
Closed -$18.4K
JBSS icon
1394
John B. Sanfilippo & Son
JBSS
$978M
-345,252
Closed -$33.5M
KNSA icon
1395
Kiniksa Pharmaceuticals
KNSA
$4.89B
-345
Closed -$6.44K
KROS icon
1396
Keros Therapeutics
KROS
$202M
-327
Closed -$14.9K
KRYS icon
1397
Krystal Biotech
KRYS
$10.4B
-238
Closed -$43.7K
KURA icon
1398
Kura Oncology
KURA
$901M
-709
Closed -$14.6K
KWR icon
1399
Quaker Houghton
KWR
$2.63B
-375
Closed -$63.6K
KYMR icon
1400
Kymera Therapeutics
KYMR
$9.05B
-517
Closed -$15.4K

Similar funds

Pacer Advisors's Q3 2024 Portfolio in Review

As of Q3 2024, Pacer Advisors held 2,836 positions worth $47.3B, up 7.2% from $44.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Pacer Advisors's Q3 2024 filing shows 148 new, 1,004 increased, 1,103 reduced and 268 closed positions. Its largest new stake was TechnipFMC: 7,077,502 shares worth $186M. The largest sale was 3M, an estimated $559M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 18% of assets, up from 17% a quarter earlier, followed by Technology and Energy.

  • Pacer Advisors's largest Q3 2024 buy was TechnipFMC: 7,077,502 shares worth $186M.
  • Pacer Advisors added most to Airbnb in Q3 2024, an estimated $541M increase.
  • Pacer Advisors's biggest Q3 2024 reduction was 3M, cutting an estimated $559M.
  • Pacer Advisors fully exited Newell Brands in Q3 2024, selling an estimated $301M.
  • Pacer Advisors's ten largest holdings make up 11% of its $47.3B portfolio in Q3 2024.
  • Pacer Advisors opened 148 new positions and closed 268 in Q3 2024.
  • Pacer Advisors's portfolio value rose 7.2% quarter-over-quarter to $47.3B.

Based on Pacer Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.